Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 32% ± 11% | |
brain | 18 studies | 33% ± 18% | |
peripheral blood | 17 studies | 33% ± 12% | |
intestine | 10 studies | 26% ± 10% | |
eye | 10 studies | 32% ± 13% | |
kidney | 8 studies | 28% ± 8% | |
heart | 5 studies | 27% ± 1% | |
lymph node | 5 studies | 34% ± 7% | |
liver | 5 studies | 37% ± 15% | |
pancreas | 4 studies | 48% ± 15% | |
placenta | 4 studies | 33% ± 11% | |
uterus | 4 studies | 41% ± 12% | |
breast | 4 studies | 40% ± 4% | |
prostate | 4 studies | 36% ± 12% | |
adipose | 4 studies | 27% ± 7% | |
bone marrow | 3 studies | 27% ± 7% | |
adrenal gland | 3 studies | 30% ± 12% | |
thymus | 3 studies | 34% ± 19% | |
esophagus | 3 studies | 31% ± 18% | |
skin | 3 studies | 37% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 4987.30 | 258 / 258 | 100% | 107.05 | 230 / 230 |
esophagus | 100% | 4051.84 | 1445 / 1445 | 100% | 43.56 | 183 / 183 |
liver | 100% | 2683.59 | 226 / 226 | 100% | 52.87 | 406 / 406 |
ovary | 100% | 4343.05 | 180 / 180 | 100% | 55.21 | 430 / 430 |
pancreas | 100% | 2734.42 | 328 / 328 | 100% | 67.46 | 178 / 178 |
stomach | 100% | 2860.34 | 359 / 359 | 100% | 51.55 | 286 / 286 |
uterus | 100% | 4115.58 | 170 / 170 | 100% | 71.60 | 459 / 459 |
lung | 100% | 4777.03 | 577 / 578 | 100% | 59.94 | 1155 / 1155 |
bladder | 100% | 3874.19 | 21 / 21 | 100% | 59.49 | 503 / 504 |
breast | 100% | 4487.54 | 459 / 459 | 100% | 74.20 | 1115 / 1118 |
thymus | 100% | 4025.99 | 653 / 653 | 100% | 74.49 | 603 / 605 |
kidney | 100% | 3409.96 | 89 / 89 | 100% | 65.67 | 898 / 901 |
brain | 100% | 3684.09 | 2632 / 2642 | 100% | 61.09 | 705 / 705 |
prostate | 100% | 3739.37 | 244 / 245 | 100% | 67.56 | 501 / 502 |
intestine | 100% | 3942.32 | 966 / 966 | 99% | 58.88 | 521 / 527 |
skin | 100% | 3772.25 | 1807 / 1809 | 97% | 50.24 | 456 / 472 |
adipose | 100% | 4610.90 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5189.96 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 59.20 | 29 / 29 |
muscle | 100% | 9304.83 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4147.58 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 60.83 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.95 | 1 / 1 |
peripheral blood | 100% | 5528.71 | 925 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 5405.82 | 856 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 37.21 | 77 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0007288 | Biological process | sperm axoneme assembly |
GO_0016567 | Biological process | protein ubiquitination |
GO_0010845 | Biological process | positive regulation of reciprocal meiotic recombination |
GO_0006281 | Biological process | DNA repair |
GO_0007283 | Biological process | spermatogenesis |
GO_0070979 | Biological process | protein K11-linked ubiquitination |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0051093 | Biological process | negative regulation of developmental process |
GO_0001701 | Biological process | in utero embryonic development |
GO_0070193 | Biological process | synaptonemal complex organization |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_1901874 | Biological process | negative regulation of post-translational protein modification |
GO_0006974 | Biological process | DNA damage response |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0051026 | Biological process | chiasma assembly |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0009411 | Biological process | response to UV |
GO_0006301 | Biological process | postreplication repair |
GO_0045141 | Biological process | meiotic telomere clustering |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0050821 | Biological process | protein stabilization |
GO_0070534 | Biological process | protein K63-linked ubiquitination |
GO_2000242 | Biological process | negative regulation of reproductive process |
GO_0006915 | Biological process | apoptotic process |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0043951 | Biological process | negative regulation of cAMP-mediated signaling |
GO_0035234 | Biological process | ectopic germ cell programmed cell death |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0033503 | Cellular component | HULC complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005657 | Cellular component | replication fork |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0001741 | Cellular component | XY body |
GO_0005634 | Cellular component | nucleus |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0061631 | Molecular function | ubiquitin conjugating enzyme activity |
GO_0005515 | Molecular function | protein binding |
Gene name | UBE2B |
Protein name | Ubiquitin-conjugating enzyme E2 B (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme B) (Ubiquitin carrier protein B) (Ubiquitin-protein ligase B) Ubiquitin conjugating enzyme E2 B Ubiquitin-conjugating enzyme E2 B (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme B) (RAD6 homolog B) (HR6B) (hHR6B) (Ubiquitin carrier protein B) (Ubiquitin-conjugating enzyme E2-17 kDa) (Ubiquitin-protein ligase B) |
Synonyms | RAD6B UBCH1 |
Description | FUNCTION: Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In association with the E3 enzyme BRE1 (RNF20 and/or RNF40), it plays a role in transcription regulation by catalyzing the monoubiquitination of histone H2B at 'Lys-120' to form H2BK120ub1. H2BK120ub1 gives a specific tag for epigenetic transcriptional activation, elongation by RNA polymerase II, telomeric silencing, and is also a prerequisite for H3K4me and H3K79me formation. In vitro catalyzes 'Lys-11'-, as well as 'Lys-48'- and 'Lys-63'-linked polyubiquitination. Required for postreplication repair of UV-damaged DNA. Associates to the E3 ligase RAD18 to form the UBE2B-RAD18 ubiquitin ligase complex involved in mono-ubiquitination of DNA-associated PCNA on 'Lys-164'. May be involved in neurite outgrowth. May play a role in DNA repair . . |
Accessions | ENST00000506787.5 P63146 ENST00000265339.7 H0YA80 D6RDW8 ENST00000510021.5 H0Y9V2 ENST00000507277.2 |